In addition to HCC, the inhibitory effect of matrine on the PI3K/AKT/mTOR pathway has also been reported in gastric cancer, acute myeloid leukemia, breast cancer, and other malignancies [9,10,38]. This evidence concerns the gene MTOR and breast carcinoma.